BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24021906)

  • 1. Mapping the Gastrointestinal Quality of Life Index to short-form 6D utility scores.
    Lee L; Kaneva P; Latimer E; Feldman LS
    J Surg Res; 2014 Jan; 186(1):135-41. PubMed ID: 24021906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
    Richardson SS; Berven S
    Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valuing postoperative recovery: validation of the SF-6D health-state utility.
    Lee L; Elfassy N; Li C; Latimer E; Liberman AS; Charlebois P; Stein B; Carli F; Fried GM; Feldman LS
    J Surg Res; 2013 Sep; 184(1):108-14. PubMed ID: 23522456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.
    Wong CK; Lam CL; Wan YF; Rowen D
    Value Health; 2013; 16(2):373-84. PubMed ID: 23538190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.
    Kalaitzakis E; Benito de Valle M; Rahman M; Lindkvist B; Björnsson E; Chapman R; Kontodimopoulos N
    Qual Life Res; 2016 Apr; 25(4):947-57. PubMed ID: 26471264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the Functional Assessment of Cancer Therapy-general or -Colorectal to SF-6D in Chinese patients with colorectal neoplasm.
    Wong CK; Lam CL; Rowen D; McGhee SM; Ma KP; Law WL; Poon JT; Chan P; Kwong DL; Tsang J
    Value Health; 2012 May; 15(3):495-503. PubMed ID: 22583460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in cochlear implantees: comparing utility values obtained through the Medical Outcome Study Short-Form Survey-6D and the Health Utility Index Mark 3.
    Arnoldner C; Lin VY; Bresler R; Kaider A; Kuthubutheen J; Shipp D; Chen JM
    Laryngoscope; 2014 Nov; 124(11):2586-90. PubMed ID: 24536018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the validity of two indirect utility instruments as measures of postoperative recovery.
    Lee L; Mata J; Augustin BR; Carli F; Morin N; Latimer E; Feldman LS
    J Surg Res; 2014 Jul; 190(1):79-86. PubMed ID: 24629417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
    Xie F; Li SC; Luo N; Lo NN; Yeo SJ; Yang KY; Fong KY; Thumboo J
    Arthritis Rheum; 2007 Aug; 57(6):1043-9. PubMed ID: 17665466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping MOS Sleep Scale scores to SF-6D utility index.
    Yang M; Dubois D; Kosinski M; Sun X; Gajria K
    Curr Med Res Opin; 2007 Sep; 23(9):2269-82. PubMed ID: 17697450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SF-6D values stratified by specific diagnostic indication.
    Carreon LY; Djurasovic M; Canan CE; Burke LO; Glassman SD
    Spine (Phila Pa 1976); 2012 Jun; 37(13):E804-8. PubMed ID: 22228327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index.
    O'Brien BJ; Spath M; Blackhouse G; Severens JL; Dorian P; Brazier J
    Health Econ; 2003 Nov; 12(11):975-81. PubMed ID: 14601159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting health-utility scores from the Cervical Spine Outcomes Questionnaire in a multicenter nationwide study of anterior cervical spine surgery.
    Skolasky RL; Carreon LY; Anderson PA; Albert TJ; Riley LH
    Spine (Phila Pa 1976); 2011 Dec; 36(25):2211-6. PubMed ID: 21343870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index.
    Dan AA; Kallman JB; Srivastava R; Younoszai Z; Kim A; Younossi ZM
    Liver Transpl; 2008 Mar; 14(3):321-6. PubMed ID: 18306356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year health-related quality of life in cochlear implant recipients: prospective SF-36 data with SF-6D conversion.
    Arnoldner C; Lin VY; Honeder C; Shipp D; Nedzelski J; Chen J
    Laryngoscope; 2014 Jan; 124(1):278-82. PubMed ID: 24122948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument from the SF-6D.
    Brazier JE; Kolotkin RL; Crosby RD; Williams GR
    Value Health; 2004; 7(4):490-8. PubMed ID: 15449641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the SF-6D value set for a population-based sample of Brazilians.
    Cruz LN; Camey SA; Hoffmann JF; Rowen D; Brazier JE; Fleck MP; Polanczyk CA
    Value Health; 2011; 14(5 Suppl 1):S108-14. PubMed ID: 21839880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.